← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Osivax Sas
Paris
$1,540,227
Total funding
1
Grants
Funding over time
peak $529.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,540,227 · 1
By mechanism
R01$1,540,227 · 1
Investigators at Osivax Sas
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model$529,857
R01 · FY2023 · AI
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model$526,307
R01 · FY2024 · AI
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model$370,152
R01 · FY2025 · AI
Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model$113,911
R01 · FY2025 · AI